Raytech (NASDAQ: RAY) closes $6.2M registered direct share offering
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Raytech Holding Limited completed a registered direct offering of 3,149,832 ordinary shares at US$1.97 per share, raising approximately US$6.2 million in gross proceeds. The shares were issued under its effective Form F-3 shelf registration statement and a June 18, 2026 prospectus supplement.
The company will use net proceeds for general corporate and working capital purposes, to support expansion into personal health care electronics, and to fund integration and post-closing working capital needs for its acquisition of Worry Free Group (Hong Kong) Limited. Affiliates Fortune Genesis Holdings Limited and WK Frater Holdings Limited each bought 999,014 shares on the same terms and agreed to a lock-up through September 20, 2026.
Positive
- None.
Negative
- None.
Key Figures
Shares sold: 3,149,832 ordinary shares
Offering price: US$1.97 per share
Gross proceeds: Approximately US$6.2 million
+4 more
7 metrics
Shares sold
3,149,832 ordinary shares
Registered direct offering closed June 29, 2026
Offering price
US$1.97 per share
Public offering price for ordinary shares
Gross proceeds
Approximately US$6.2 million
Aggregate gross proceeds before fees and expenses
Placement fee
US$50,000 cash
Fixed transaction fee to placement agent at closing
Expense reimbursement cap
Up to US$5,000
Reimbursement of placement agent out-of-pocket expenses
Affiliated investor purchase
999,014 shares each
Shares bought by Fortune Genesis and WK Frater
Lock-up period end
September 20, 2026
Lock-up on shares purchased by affiliated investors
Key Terms
registered direct offering, shelf registration statement, foreign private issuer, Nasdaq Listing Rule 5615(a)(3), +2 more
6 terms
registered direct offering financial
"announces Closing of Approximately $6.2 Million Registered Direct Offering of its Ordinary Shares"
A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.
shelf registration statement regulatory
"offered pursuant to a shelf registration statement on Form F-3 (File No. 333-290696)"
A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Nasdaq Listing Rule 5615(a)(3) regulatory
"relied on the foreign private issuer home country practice exemption under Nasdaq Listing Rule 5615(a)(3)"
lock-up financial
"each of the Affiliated Investors agreed to a lock-up, subject to customary exceptions"
A lock-up is an agreement that prevents company insiders, early investors or employees from selling their shares for a set period after a public share offering. It matters to investors because it temporarily limits the number of shares available to trade—like a scheduled hold on extra inventory—and when that hold ends a large number of shares can enter the market, potentially putting downward pressure on the stock price and revealing insiders’ confidence in the company.
Form F-3 regulatory
"registration statement on Form F-3 (File No. 333-290696), declared effective"
Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.
FAQ
What did Raytech Holding Limited (RAY) announce in this Form 6-K?
Raytech Holding Limited announced the closing of a registered direct offering of 3,149,832 ordinary shares at US$1.97 per share, generating approximately US$6.2 million in gross proceeds to support corporate purposes, expansion into personal health care electronics, and integration of Worry Free Group.
How large was Raytech (RAY)'s registered direct offering and at what price?
Raytech sold 3,149,832 ordinary shares at a public offering price of US$1.97 per share. This transaction generated approximately US$6.2 million in aggregate gross proceeds before deducting placement agent fees and other offering expenses, providing additional capital for its stated business initiatives.
What lock-up arrangements apply to affiliated investors in Raytech (RAY)'s offering?
Each affiliated investor agreed to a lock-up under Section 4.1 of its securities purchase agreement. The lock-up covers the ordinary shares they bought from closing through September 20, 2026, subject to customary exceptions, restricting their ability to dispose of these shares during that period.
How will Raytech Holding Limited (RAY) use the net proceeds from the offering?
Raytech intends to use net proceeds for general corporate and working capital purposes, to support strategic expansion into the personal health care electronics product category, and to cover integration and post-closing working capital requirements related to its acquisition of Worry Free Group (Hong Kong) Limited.